Candidemia: A nosocomial complication in adults with late-stage AIDS

Clinical Infectious Diseases

Volumn 26, Issue 5, 1998, Pages 1134-1141

  Launay, Odile ^b   Lortholary, Olivier ^a   Bouges Michel, Claire ^b   Jarrousse, Bernard ^b   Bentata, Michèle ^b   Guillevin, Loïc ^b  

^a UNIVERSITÉ PARIS 13   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDIASIS; FEMALE; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTIOUS COMPLICATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0031897850     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520291     Document Type: Article

References (21)

1. Diamond RD. The growing problem of mycoses in patients infected with the human immunodeficiency virus. Rev Infect Dis 1991;13:480-6.
2. He X, Tiballi RN, Zarins LT, Bradley SF, Sangeorzan JA, Kaufman CA. Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1994;38:2495-7.
3. Johnson EM, Warnock DW, Luker J, Porter SR, Scully C. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidiasis. J Antimicrob Chemother 1995;35:103-14.
4. Maenza JR, Merz WG, Romagnoli MJ, Keruly JC, Moore RD, Gallant JE. Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology. Clin Infect Dis 1997;24:28-34.
5. Ruhnke M, Eigler A, Geiseler B, Engelmann E, Trautmann M. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol 1994;32:2092-8.
6. Bruun B, Westh H, Stenderup J. Fungemia: an increasing problem in a Danish university hospital, 1989 to 1994. Clin Microbiol Infect 1996;1:124-6.
7. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996;9:499-511.
8. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Clairbone Dunagan W. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992;15:414-21.
9. Harvey RL, Myers JP. Nosocomial fungemia in a large community teaching hospital. Arch Intern Med 1987;147:2117-20.
10. Horn R, Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985;7:646-55.
11. Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics and evaluation of factors influencing outcome. Rev Infect Dis 1989;11:379-90.
12. Meunier-Carpentier F, Kiehn TE, Armstrong D. Fungemia in the immunocompromised host: changing patterns, antigenemia, high mortality. Am J Med 1981;71:363-70.
13. Meunier F, Aoun M, Bitar N. Candidemia in immunocompromised patients. Clin Infect Dis 1992;14(suppl 1):S120-5.
14. Nolte FS, Parkinson T, Falconer DJ, et al. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrob Agents Chemother 1997;44:196-9.
15. Price MF, La Rocco MT, Gentry LO. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother 1994;38:1422-4.
16. Akova M, Akalin HE, Uzun Ö, Gür D. Emergence of Candida krusei after therapy of oropharyngeal candidiasis with fluconazole. Eur J Clin Microbiol Infect Dis 1991;10:598-9.
17. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274-7.
18. Girmenia C, Martino P, De Bernardis F, et al. Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains. Clin Infect Dis 1996;23:506-14.
19. Leibovitz E, Rigaud M, Chandwani S, et al. Disseminated fungal infections in children infected with human immunodeficiency virus. Pediatr Infect Dis 1991;10:888-94.
20. Walsh TJ, Gonzales CE, Roilides E, et al. Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, pathogens, and improved outcome with antifungal therapy. Clin Infect Dis 1995;20:900-6.
21. Gonzales CE, Venzon D, Lee S, Mueller BU, Pizzo PA, Walsh TJ. Risk factors of fungemia in children infected with human immunodeficiency virus: a case-control study. Clin Infect Dis 1996;23:515-21.